In accordance with statistics bulletin and related statistical information, the Medical Industry Major Economic Indicator performance of 2015 is as follows:

I. Industrial Added Value

In 2015, the added value of above-scale medical & pharmaceutical industry increased by 9.8% on year-on-year basis, with a drop growth rate of 2.7% compared with that in the previous year, 3.7% higher than the overall industrial growth rate. The added value of medical & pharmaceutical industry shared 3.0% of overall industrial added value, about 0.2% higher than that in the previous year, reflecting the further contribution of medical & pharmaceutical industry to overall industrial growth.

II. Main Business Income

In 2015, the main business income of above-scale medical & pharmaceutical enterprises reached CNY 2688.519 billion, increased by 9.02% on year-on-year basis, higher than the national industrial growth of 8.22%, but decreased by 4.42% compared with that in the previous year. Among sub-industries, the growth of Chinese patent medicine and pharmaceutical equipment was lower than the average level.

III. Profits

In 2015, the total profit of above-scale medical & pharmaceutical enterprises reached CNY 276.823 billion, increased by 12.22% on year-on-year basis, higher than the national industrial growth of 14.52%, but decreased by 0.93% compared with that in the previous year. The full-year profit growth was higher than that of main business income, indicating the improvement of medical & pharmaceutical industry profitability.

IV. Amount of Exports

In 2015, the export delivery value of above-scale medical & pharmaceutical enterprises reached CNY 179.85 billion, increased by 3.6% on year-on-year basis, with drop growth rate of 6.1% compared with that in the previous year. According to the import and export data from the Customs, in 2015, the amount of export of pharmaceutical products was USD 56.44 billion, increased by 2.7% on year-on-year basis, with drop growth rate of 4.7% compared with that in the previous year. Export structure was improved, chemical drug and preparation, medical instrument and equipment export proportion was increased.

V. Fixed-asset Investment

In 2015, the fixed-asset investment in medical & pharmaceutical products was CNY 581.2 billion, increased by 11.9% on year-on-year basis, with a drop growth rate of 3.2% compared with that in the previous year, 4.2% higher than the overall industrial growth rate in China. While the rapid increase was kept, the GMP upgrade, new plant construction-focused technological transformation of enterprises was decreased gradually since “the twelfth five-year plan”.